Creative Medical Technology Holdings, Inc. (CELZ)
1.04
-0.04
(-3.70%)
USD |
NASDAQ |
Sep 09, 16:00
1.04
0.00 (0.00%)
After-Hours: 16:48
Creative Medical Technology Holdings Shareholders Equity (Quarterly) : 8.655M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.655M |
| March 31, 2026 | 6.110M |
| December 31, 2025 | 7.515M |
| September 30, 2025 | 5.592M |
| June 30, 2025 | 6.828M |
| March 31, 2025 | 8.061M |
| December 31, 2024 | 6.342M |
| September 30, 2024 | 6.557M |
| June 30, 2024 | 7.613M |
| March 31, 2024 | 9.229M |
| December 31, 2023 | 10.34M |
| September 30, 2023 | 12.09M |
| June 30, 2023 | 13.73M |
| March 31, 2023 | 14.82M |
| December 31, 2022 | 15.86M |
| September 30, 2022 | 22.07M |
| June 30, 2022 | 23.04M |
| March 31, 2022 | 9.354M |
| December 31, 2021 | 10.22M |
| September 30, 2021 | -0.3633M |
| June 30, 2021 | -0.7145M |
| March 31, 2021 | -2.443M |
| December 31, 2020 | -39.80M |
| September 30, 2020 | -2.776M |
| June 30, 2020 | -4.205M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.182M |
| December 31, 2019 | -8.072M |
| September 30, 2019 | -3.563M |
| June 30, 2019 | -2.637M |
| March 31, 2019 | -3.605M |
| December 31, 2018 | -3.995M |
| September 30, 2018 | -7.354M |
| June 30, 2018 | -10.59M |
| March 31, 2018 | -7.934M |
| December 31, 2017 | -2.236M |
| September 30, 2017 | -1.073M |
| June 30, 2017 | -1.023M |
| March 31, 2017 | -0.2997M |
| December 31, 2016 | -0.1578M |
| September 30, 2016 | -0.3352M |
| June 30, 2016 | -0.2514M |
| March 31, 2016 | -0.1889M |
| December 31, 2015 | -0.1838M |
| September 30, 2015 | -0.1749M |
| June 30, 2015 | -0.1686M |
| March 31, 2015 | -0.1623M |
| December 31, 2014 | -0.153M |
| September 30, 2014 | -0.1465M |
| June 30, 2014 | -0.1408M |
| March 31, 2014 | -0.135M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.378M |
| Total Liabilities (Quarterly) | 0.6986M |
| Current Ratio | 12.91 |